Essentials of Pharmacoeconomics
Livrare gratis la comenzi peste 500 RON. Pentru celelalte comenzi livrarea este 20 RON.
Disponibilitate: La comanda in aproximativ 4 saptamani
Autor: Karen Rascati
Editura: LWW
Limba: Engleza
Nr. pagini: 368
Coperta: Paperback
Dimensiuni: 17.53 x 1.52 x 25.15 cm
An aparitie: 21 Oct. 2020
Description:
Designed as a true introduction to the subject, Essentials of Pharmacoeconomics: Health Economics and Outcomes Research, ThirdEdition includes information on fundamental topics, defines terminology, and provides examples for evaluating published research, making it perfect for any pharmacy student or practitioner new to the topic. This updated edition provides the critical foundations of knowledge for measuring costs and health-related quality-of-life (HRQoL) and evaluating the four types of studies (CMA, CEA, CUA, and CBA); it also explains Markov and Budget Impact Analysis modeling, and discusses the advantages and disadvantages of using retrospective databases and real-world data (RWD). Additionally, the text summarizes the use of pharmacoeconomic evaluations by decision makers outside of the United States and the extent to which pharmacoeconomic data are used to make decisions in the United States, includes barriers to its use, and discusses future issues. All of this information is designed to ensure preparedness to improve clinical and humanistic outcomes based on available resources.
- Digital version available. Fast, smart, and convenient, today’s digital version can transform learning. These interactive, fully searchable tools offer 24/7 access on multiple devices, the ability to highlight and share notes, and much more.
Table of Contents:
PART I • BASIC TOPICS CHAPTER 1 Introduction
PHARMACOECONOMICS—WHAT IS IT?
WHY IS PHARMACOECONOMICS IMPORTANT?
RELATIONSHIP OF PHARMACOECONOMICS TO OTHER RESEARCH
TYPES OF PHARMACOECONOMIC STUDIES
SUMMARY
QUESTIONS/EXERCISES
REFERENCES
SUGGESTED READINGS
CHAPTER 2 Measuring and Estimating Costs
COSTING TERMS
COST CATEGORIZATION
ALTERNATIVE METHODS OF CATEGORIZATION OF COSTS
PERSPECTIVE
TIMING ADJUSTMENTS FOR COSTS
RESOURCES FOR COST ESTIMATIONS
SUMMARY
QUESTIONS/EXERCISES
REFERENCES
SUGGESTED READINGS
CHAPTER 3 Critiquing Research Articles
APPROPRIATENESS OF METHODS OF ANALYSIS
QUESTIONS TO USE WHEN CRITIQUING RESEARCH ARTICLES
SUMMARY
QUESTIONS/EXERCISES
REFERENCES
SUGGESTED READINGS
CHAPTER 4 Cost-Minimization Analysis
OVERVIEW
SUMMARY
REFERENCES
SUGGESTED READINGS
CHAPTER 5 Cost-Effectiveness Analysis
OVERVIEW
PRESENTATION OF COSTS AND EFFECTIVENESS
COST-EFFECTIVENESS GRID
COST-EFFECTIVENESS PLANE
INTERMEDIATE OUTCOMES VERSUS PRIMARY OUTCOMES
EFFICACY VERSUS EFFECTIVENESS
CONSENSUS AND DEBATE
SUMMARY
QUESTIONS/EXERCISES
REFERENCES
SUGGESTED READINGS
CHAPTER 6 Cost-Utility Analysis
OVERVIEW
STEPS IN CALCULATING QALYS
TRENDS IN CUA ANALYSES
INCREMENTAL NET BENEFIT
CONCERNS ABOUT USING QALYS
SUMMARY
QUESTIONS/EXERCISES
REFERENCES
SUGGESTED READINGS
CHAPTER 7 Cost-Benefit Analysis
DEFINITION AND HISTORY
ADVANTAGES AND DISADVANTAGES OF CBA
CONDUCTING A CBA
DIFFERENCE BETWEEN COSTS AND BENEFITS
MEASURING INDIRECT AND INTANGIBLE BENEFITS
CALCULATING RESULTS OF COSTS AND BENEFITS
SUMMARY
QUESTIONS/EXERCISES
REFERENCES
SUGGESTED READINGS
CHAPTER 8 Health-Related Quality of Life: Health Status Measures
DEFINITIONS
HRQoL MEASURES VERSUS UTILITY MEASURES
DOMAINS OF HEALTH STATUS
ASSESSING HRQoL INSTRUMENTS
PHARMACOECONOMICS AND HRQoL MEASURES
PREFERENCE-BASED CLASSIFICATION SYSTEMS
PATIENT-REPORTED OUTCOMES
SUMMARY
QUESTIONS/EXERCISES
REFERENCES
SUGGESTED READINGS
PART II • ADVANCED TOPIC CHAPTER 9 Decision Analysis
WHAT IS DECISION ANALYSIS?
STEPS IN DECISION ANALYSIS
THRESHOLD ANALYSIS
SUMMARY
QUESTIONS/EXERCISE
REFERENCES
SUGGESTED READINGS
CHAPTER 10 Markov Modeling
OVERVIEW
STEPS IN MARKOV MODELING
DISADVANTAGES OF MARKOV MODELING
ADVANCED ISSUES
OTHER ADVANCED TOPICS
SUMMARY
QUESTIONS/EXERCISES
REFERENCES
SUGGESTED READINGS
CHAPTER 11 Real-World Data/Real-World Evidence
DEFINITIONS OF REAL-WORLD DATA AND REAL-WORLD EVIDENCE
OVERVIEW OF RWD AND RWE
RANDOMIZED CONTROLLED TRIALS
REAL-WORLD EVIDENCE
ADVANTAGES AND DISADVANTAGES OF RCTS
ADVANTAGES AND DISADVANTAGES OF RWE
USE OF RWD/RWE
TYPES OF RETROSPECTIVE DATABASES
INSURANCE AND CLAIMS RECORDS
REGISTRIES
CRITIQUING RWD STUDIES
SUMMARY
QUESTIONS/EXERCISES
REFERENCES
SUGGESTED READINGS
CHAPTER 12 Budget-Impact Analysis*
OVERVIEW
DIFFERENCES BETWEEN BUDGET-IMPACT ANALYSIS AND COST-EFFECTIVENESS ANALYSIS
SIX-STEP APPROACH TO BUDGET-IMPACT ANALYSIS
IMPLEMENTING BUDGET-IMPACT ANALYSES
SUMMARY
QUESTIONS/EXERCISES
REFERENCES
SUGGESTED READING
CHAPTER 13 Pharmacy Services
WHAT ARE PHARMACY SERVICES?
HISTORY OF PHARMACY SERVICES
MEDICATION THERAPY MANAGEMENT
REVIEW OF THE ECONOMIC RESEARCH
SUMMARY
QUESTIONS/EXERCISES
REFERENCES
SUGGESTED READINGS
CHAPTER 14 International Perspective
HEALTH CARE EXPENDITURES
COMPARABILITY OF PHARMACOECONOMIC RESULTS BETWEEN COUNTRIES
HISTORY OF PHARMACOECONOMIC GUIDELINE DEVELOPMENT
SUMMARY
QUESTIONS/EXERCISES
REFERENCES
SUGGESTED READINGS
CHAPTER 15 Future Issues
APPLICATION OF PHARMACOECONOMICS IN THE UNITED STATES
BARRIERS TO PHARMACOECONOMICS IN THE UNITED STATES
VALUE-BASED FRAMEWORKS
CURATIVE THERAPIES
VALUE-BASED ALTERNATIVE PAYMENT METHODS
SUMMARY
REFERENCES
SUGGESTED READINGS
Answers to Questions/Exercises
Glossary
Index
An aparitie | 21 Oct. 2020 |
Autor | Karen Rascati |
Dimensiuni | 17.53 x 1.52 x 25.15 cm |
Editura | LWW |
Format | Paperback |
ISBN | 9781975139445 |
Limba | Engleza |
Nr pag | 368 |
Clientii ebookshop.ro nu au adaugat inca opinii pentru acest produs. Fii primul care adauga o parere, folosind formularul de mai jos.